List view / Grid view

Mergers & Acquisitions

news

Novo Nordisk set to acquire Emisphere for $1.8 billion

12 November 2020 | By Victoria Rees (European Pharmaceutical Review)

Following approval by Emisphere shareholders, Novo Nordisk will acquire the company for a total of $1.8 billion.

news

Merck to acquire VelosBio for $2.75 billion

10 November 2020 | By Hannah Balfour (European Pharmaceutical Review)

The acquisition will strengthen Merck’s oncology pipeline with VLS-101, an investigational antibody-drug conjugate in trials for haematological malignancies and solid tumours.

news

Pharma M&A activity up 17 percent year-on-year in H1 of 2020

5 November 2020 | By Victoria Rees (European Pharmaceutical Review)

A new report has highlighted that despite the pandemic, pharma M&A activity rose but deal value fell in the first half of 2020.

news

PerkinElmer to acquire Horizon Discovery for $383 Million

2 November 2020 | By Hannah Balfour (European Pharmaceutical Review)

PerkinElmer will expand its automated life sciences discovery and applied genomics solutions with the acquisition.

article

How can virtual pharma companies de-risk new product launches?

5 October 2020 | By Christoph Krähenbühl (Excellis Europe)

Christoph Krähenbühl outlines five considerations for virtual pharmaceutical companies when launching a new drug product.

news

Majority of CMO-acquired dose manufacturing facilities in Europe, report says

5 October 2020 | By Victoria Rees (European Pharmaceutical Review)

A new report has found that three quarters of dose manufacturing facilities acquired by dedicated CMOs in 2019 were in Europe.

news

Gilead Sciences to acquire Immunomedics for $21 billion

17 September 2020 | By Victoria Rees (European Pharmaceutical Review)

Gilead is set to acquire Immunomedics for approximately $21 billion, with the transaction anticipated to close in the fourth quarter of 2020.

news

Nestlé Health Science to acquire Aimmune Therapeutics for $2.6 billion

1 September 2020 | By Victoria Rees (European Pharmaceutical Review)

Nestlé Health Science will acquire Aimmune Therapeutics for a total value of $2.6 billion, extending the former's food allergy portfolio.

news

Sanofi to acquire Principa Biopharma for $3.68 billion

20 August 2020 | By Victoria Rees (European Pharmaceutical Review)

Sanofi is set to acquire Principia Biopharma Inc. for a total aggregate equity value of $3.68 billion, at $100 per share.

news

Bayer to acquire KaNDy Therapeutics with $425 million upfront payment

14 August 2020 | By Victoria Rees (European Pharmaceutical Review)

Bayer will acquire KaNDy Therapeutics Ltd for an upfront cost of $425 million to expand its drug development pipeline in women’s healthcare.

news

Licensing agreement deals decline in rare diseases space, says report

11 August 2020 | By Victoria Rees (European Pharmaceutical Review)

New research has shown that complex collaborations and partnerships are increasing, while licensing agreements are decreasing in the rare disease space.

article

Outsourcing update: the latest developments in pharma

15 July 2020 | By Hannah Balfour (European Pharmaceutical Review)

European Pharmaceutical Review explores some of the latest developments in outsourcing, including clinical development and production agreements; acquisitions and collaborations; and expansions.

article

Life sciences M&A activity during the global pandemic

25 June 2020 | By Russell Hoare (CMS), Theo Godfrey (CMS)

COVID-19 has severely disrupted the lives of many people around the world. In this article, corporate partner Theo Godfrey and competition partner Russell Hoare from the life sciences team at law firm CMS Cameron McKenna Nabarro Olswang LLP consider some issues related to COVID-19 that have impacted life sciences merger…

news

FTC accepts proposal for AbbVie to acquire Allergan for $63 billion

11 May 2020 | By Victoria Rees (European Pharmaceutical Review)

AbbVie and Allergan have announced the Federal Trade Commission has accepted AbbVie's pending acquisition of Allergan for $63 billion.

news

Sartorius closes acquisition of selected assets of Danaher Life Sciences

1 May 2020 | By Sartorius

Sartorius has announced the completed acquisition of some life science businesses of Danaher for a total of $825 million.

Cookie	Description
cookielawinfo-checkbox-advertising-targeting	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged	This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.

Cookie	Description
cf_ob_info	This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob	This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only	This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush	This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db	This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC	This cookie is set by Youtube and is used to track the views of embedded videos.

Cookie	Description
bcookie	This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS	This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang	This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc	This cookie is set by LinkedIn and used for routing.
lissc	This cookie is set by LinkedIn share Buttons and ad tags.
vuid	We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId	This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule	This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session	This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues	This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga	This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat	This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid	This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.

Cookie	Description
advanced_ads_browser_width	This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions	This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info	This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer	This cookie is set by Advanced Ads and sets the referrer URL.
bscookie	This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE	This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr	This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory	This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE	This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.

Recommended

Mergers & Acquisitions